Demographic data of solid tumor patients undergoing systemic cytotoxic chemotherapy and using prophylactic entecavir or lamivudine.

Abstract

<p><sup><i>a</i></sup>Entecavir group included 6 head and neck cancers, 4 gynecologic cancers, and 7 genitourinary cancers. Lamivudine group included 31 head and neck cancers, 15 gynecologic cancers, and 11 genitourinary cancers.</p><p><sup><i>b</i></sup>SCC: systemic cytotoxic chemotherapy</p><p><sup><i>c</i></sup>ALT: alanine aminotransferase.</p><p><sup><i>d</i></sup>INR: international normalized ratio.</p><p>Demographic data of solid tumor patients undergoing systemic cytotoxic chemotherapy and using prophylactic entecavir or lamivudine.</p

    Similar works

    Full text

    thumbnail-image

    Available Versions